PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical

Experts call for advanced radiotherapy funding to address COVID-19 cancer care backlog

The Institute for Cancer Research, London (ICR) is urging the government to invest in advanced radiotherapy in a bid to address the backlog in NHS cancer care that has accumulated during the COVID-19 pandemic.
ICR is calling on the government to address funding gaps for high-precision radiotherapy, and also combat patient scepticism of radiotherapy as an ‘outdated’ treatment.
As well as increased funding, ICR added that a nationally coordinated approach to support delivery of the latest radiotherapy research advances is also needed.
This comes as a survey of 2,5000 people demonstrated widespread misconceptions about radiotherapy, with only 8% of respondents from the general population considering radiotherapy to be cutting-edge.
This is much lower compared with the 50% for targeted drugs, 43% for immunotherapy and 58% for proton beam therapy.
ICR commented that research over the last 20 years has been ‘highly’ successful at targeting radiation more successfully at tumours using advanced imaging and delivering radiotherapy in streamlined regimens.
New techniques, however, are often restricted to major specialist centres, meaning patients are missing out or have to travel long distances to receive treatments or participate in clinical trials.
ICR added that during the pandemic, radiotherapy could offer a safer treatment option compared to chemotherapy or surgery in certain cases, as it involves fewer and shorter visits to the hospital.
“We are urging the Government to invest in radiotherapy, for the immediate benefit of cancer patients during the pandemic, and in the long term to put in place access to clinical trials and new radiotherapy technologies in every part of the UK,” said Kevin Harrington, head of radiotherapy and imaging at ICR.
“Radiotherapy is the unsung hero of cancer treatments but so often it isn’t seen as a funding priority. We have to address radiotherapy’s PR problem, persuade patients that this treatment is cutting edge and highly sophisticated, and put in place systems to support nationwide clinical trials and the rollout of new technologies,” he added.

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026